维普中文期刊产品整合服务
189篇 您的检索式:作者名="Andersen MJ"
    题名 作者 年代 出处 被引量
1射血分数保留的心力衰竭患者动脉硬化与运动的相关性显示文摘人类衰老以主动脉僵硬度增加为特征,通过降低动脉顺应性和增强收缩期波反射造成收缩期高血压。老年、高血压和肥胖是射血分数保留的心力衰竭(heart failure with preserved ejection fraction, HFpEF)发生发展最大的影响因素.Reddy YNV Andersen MJ Obokata M Koepp KE Kane GC Melenovsky V Olson TP Borlaug BA 练桂丽 叶鹏 2017中华高血压杂志2017,25,10:10
2Improvements in sur- vival and clinical benefit with gemeitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial 显示文摘Burris HA 3^rd Moore MJ Andersen J 1997J Clin Oncal1997,15,:1
3Improvements in survival and clinical benefit with gemcitabine flrst-time therapy for patients with advanded pancreas cancer: Arandimized trial显示文摘Burris HA Moore MJ Andersen J 1997J Clin Oncol1997,15,:1
4Delayed-type hypersensitivity responses to ESAT-6and MPT64 from Mycobacterium tuberculosis in the guinea pig显示文摘Elhay MJ Oettinger T Andersen P 1998Infect Immun1998,66,7:1
5Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE) 显示文摘Raaschou-Nielsen 0 Andersen ZJ Beelen R Samoli E Stafoggia M Weinmayr G Hoffmann B Fischer P Nieuwenhuijsen MJ Brunekreef B Xun WW Katsouyanni K Dimakopoulou K Sommar J Forsberg B Modig L Oudin A Oftedal B Schwarze PE Nafstad p De Faire U Pedersen NL Ostenson CG Fratiglioni L Penell J Korek M Pershagen G Eriksen KT Serensen M Tjenneland A Ellermann T Eeftens M Peeters PH Meliefste K Wang M Bueno-de-Mesquita B Key TJ de Hoogh K Concin H Nagel G Yilier A Grioni S Krogh y Tsai MY Ricceri F Sacerdote C Galassi C Migliore E Ranzi A Cesaroni G Badaloni C Forastiere F Tamayo I Amiano P Dorronsoro M Trichopoulou A Bamia C Yineis p Hoek G 2013Lancet Oncol2013,14,9:1
6Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial 显示文摘Burris HA 3rd Moore MJ Andersen J 1997J Clin Oncol1997,15,6:1
7Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients显示文摘Agarwal R Andersen MJ Bishu K 0,,:1
8Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:A randomized trial显示文摘Burris HA 3rd Moore MJ Andersen J 1997J Clin Oncol1997,15,6:1
9Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial显示文摘Burris HA 3rd Moore MJ Andersen J 1997J Clin Oncol1997,15,6:1
10Improvements in survival and clinical Benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial 显示文摘Burris HA 3rd Moore MJ Andersen J 1997J Clin Oncol1997,15,:1
11Home blood pressure monitoring improves the diagnosis of hyperten- sion in hemodialysis patients 显示文摘Agarwal R Andersen MJ Bishu K 2006Kidney Int2006,69,5:1
12Improvements in sur- vival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: A randomized trial显示文摘Burris HA Moore MJ Andersen J 1997J Clin Oncol1997,15,6:1
13Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial显示文摘Burris HA 3rd Moore MJ Andersen J 1997JClin Oncol1997,15,6:1
14Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial显示文摘Burris HA 3rd Moore MJ Andersen J 0,,:1
15Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial显示文摘Burris HA 3rd Moore MJ Andersen J 1997J Clin Oncol1997,15,6:1
16Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from mycobacterium tuberculosis in the guinea pig显示文摘Elhay MJ Oettinger T Andersen P 1998Infect Immun1998,66,:1
17The oligosaccharides of glycoproteins:bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties显示文摘Goochee CF Gramer MJ Andersen DC 1991Biotechnology(N Y)1991,9,12:1
18Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer : a randomized trial显示文摘Burris HA Moore MJ Andersen J 1997J Clin Oncol1997,15,:1
19Improvements in sinviral and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial显示文摘Burfis HA Moore MJ Andersen J 1997J Clin Oncol1997,15,6:1
20Chronicity, severity, and timing of maternal depressive symptoms:relationships with child outcomes at age 5 显示文摘Brennan PA Hammen C Andersen MJ 2000Dev Psychol2000,36,6:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费